PatientsVille.com Logo


Xalacom Medical Research Studies

Up-to-date List of Xalacom Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Xalacom Medical Research Studies

Rank Status Study
1 Unknown  Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom
Conditions: Glaucoma;   Hypertension
Intervention: Device: Xal-Ease
Outcome Measures: Consumption of Xalatan/Xalacom bottles per year per patient.;   Evaluating cost of Xalatan/Xalacom eye drops use per year with Xal-Ease;   Characterizing the optimal conditions for proper usage of the Xal-Ease device
2 Unknown  Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Conditions: Retina;   Ocular Physiology
Interventions: Drug: latanoprost 0.005% + timolol 0,5% fixed combination;   Drug: brimonidine 0,2% + timolol 0,5% fixed combination
Outcome Measures: Optic disc blood flow measured with laser Doppler flowmeter (rel units);   Intraocular pressure (mmHg);   Retrobulbar flow velocities as measured with color Doppler imaging (cm/s);   Mean defect of visual field measured with automated perimetry (dB);   Corneal thickness as measured with pachymetry (µm)

These studies may lead to new treatments and are adding insight into Xalacom etiology and treatment.

A major focus of Xalacom research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Xalacom